Skip to main content
main-content
Top

Hint

Swipe to navigate through the chapters of this book

2018 | OriginalPaper | Chapter

Reconfigurable Nucleic Acid Materials for Cancer Therapy

Authors: Morgan Chandler, Weina Ke, Justin R. Halman, Martin Panigaj, Kirill A. Afonin

Published in: Nanooncology

Publisher: Springer International Publishing

share
SHARE

Abstract

According to the WHO, we can expect the rise of around 24 million new cases of cancer per year by around 2030 worldwide, which is a 70% increase from 2012. The molecular key players leading to cancer are heterogeneous in respect to tissue origin and may vary from patient to patient, calling for an individualized approach. Nucleic acid biopolymers (DNA and RNA) lend themselves toward applications in personalized therapeutics with high programmability based on their primary structure of five building blocks as well as biocompatibility based on established roles and functional abilities in vivo. Based on the last decades of advances in synthetic methods and natural functions of RNA, various pathways for the regulation of gene expression and DNA/RNA protein binding pathways have been uncovered, leading to the development of novel nanoparticle formulations with governing design principles. For the translation of such approaches into the clinic, the immunogenicity, strategies for delivery, and integration of mechanisms for conditional activation of therapeutic nucleic acids are explored.
Literature
1.
go back to reference Cech TR, Steitz JA (2014) The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157:77–94 CrossRef Cech TR, Steitz JA (2014) The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157:77–94 CrossRef
2.
go back to reference Wu C et al (2013) Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy. J Am Chem Soc 135:18644–18650 CrossRef Wu C et al (2013) Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy. J Am Chem Soc 135:18644–18650 CrossRef
3.
go back to reference Kruspe S, Giangrande PH (2017) Aptamer-siRNA chimeras: discovery, progress, and future prospects. Biomedicines 5(3):45 CrossRef Kruspe S, Giangrande PH (2017) Aptamer-siRNA chimeras: discovery, progress, and future prospects. Biomedicines 5(3):45 CrossRef
4.
go back to reference Catuogno S et al (2015) Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates. J Controlled Release: Official Journal of the Controlled Release Society Catuogno S et al (2015) Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates. J Controlled Release: Official Journal of the Controlled Release Society
5.
go back to reference Porciani D et al (2015) Aptamer-mediated codelivery of doxorubicin and NF-κB decoy enhances chemosensitivity of pancreatic tumor cells. Mol Ther Nucleic Acids 4:e235 CrossRef Porciani D et al (2015) Aptamer-mediated codelivery of doxorubicin and NF-κB decoy enhances chemosensitivity of pancreatic tumor cells. Mol Ther Nucleic Acids 4:e235 CrossRef
6.
go back to reference Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44:6549–6563 CrossRef Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44:6549–6563 CrossRef
7.
go back to reference Subramanian N et al (2015) Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery. Chem Commun (Cambridge, England) 51:6940–6943 CrossRef Subramanian N et al (2015) Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery. Chem Commun (Cambridge, England) 51:6940–6943 CrossRef
8.
go back to reference Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (New York, N.Y.) 249:505–510 CrossRef Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (New York, N.Y.) 249:505–510 CrossRef
9.
go back to reference Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822 CrossRef Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822 CrossRef
10.
go back to reference Catuogno S, Esposito CL (2017) Aptamer cell-based selection: overview and advances. Biomedicines 5(3):49 CrossRef Catuogno S, Esposito CL (2017) Aptamer cell-based selection: overview and advances. Biomedicines 5(3):49 CrossRef
11.
go back to reference Shangguan D et al (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838–11843 CrossRef Shangguan D et al (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838–11843 CrossRef
12.
go back to reference Chen HW et al (2008) Molecular recognition of small-cell lung cancer cells using aptamers. Chem Med Chem 3:991–1001 CrossRef Chen HW et al (2008) Molecular recognition of small-cell lung cancer cells using aptamers. Chem Med Chem 3:991–1001 CrossRef
13.
go back to reference Wang J et al (2017) In vitro selection of DNA aptamers against renal cell carcinoma using living cell-SELEX. Talanta 175:235–242 CrossRef Wang J et al (2017) In vitro selection of DNA aptamers against renal cell carcinoma using living cell-SELEX. Talanta 175:235–242 CrossRef
14.
go back to reference Li X et al (2014) In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging. Anal Chem 86:6596–6603 CrossRef Li X et al (2014) In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging. Anal Chem 86:6596–6603 CrossRef
15.
go back to reference McNamara JO et al (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24:1005–1015 CrossRef McNamara JO et al (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24:1005–1015 CrossRef
16.
go back to reference Panigaj M, Reiser J (2016) Aptamer guided delivery of nucleic acid-based nanoparticles. DNA RNA Nanotechnol 2(1):42–52 Panigaj M, Reiser J (2016) Aptamer guided delivery of nucleic acid-based nanoparticles. DNA RNA Nanotechnol 2(1):42–52
17.
go back to reference Zhou J, Rossi J (2017) Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discovery 16:181–202 CrossRef Zhou J, Rossi J (2017) Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discovery 16:181–202 CrossRef
18.
go back to reference Huang B-T et al (2017) A CTLA-4 antagonizing DNA aptamer with antitumor effect. Mol Ther Nucleic Acids 8:520–528 CrossRef Huang B-T et al (2017) A CTLA-4 antagonizing DNA aptamer with antitumor effect. Mol Ther Nucleic Acids 8:520–528 CrossRef
19.
go back to reference Yunn N-O et al (2015) Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. Nucleic Acids Res 43:7688–7701 CrossRef Yunn N-O et al (2015) Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. Nucleic Acids Res 43:7688–7701 CrossRef
20.
go back to reference Liu J et al (2016) Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials 91:44–56 CrossRef Liu J et al (2016) Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials 91:44–56 CrossRef
21.
go back to reference Zhu G et al (2013) Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci USA 110:7998–8003 CrossRef Zhu G et al (2013) Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci USA 110:7998–8003 CrossRef
22.
go back to reference Luo Z et al (2017) Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates. J Colloid Interface Sci 490:783–796 CrossRef Luo Z et al (2017) Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates. J Colloid Interface Sci 490:783–796 CrossRef
23.
go back to reference Liu X et al (2011) Targeted cell-cell interactions by DNA nanoscaffold-templated multivalent bispecific aptamers. Small (Weinheim an Der Bergstrasse, Germany) 7:1673–1682 CrossRef Liu X et al (2011) Targeted cell-cell interactions by DNA nanoscaffold-templated multivalent bispecific aptamers. Small (Weinheim an Der Bergstrasse, Germany) 7:1673–1682 CrossRef
24.
go back to reference Schrand B et al (2014) Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy. Cancer Immunol Res 2:867–877 CrossRef Schrand B et al (2014) Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy. Cancer Immunol Res 2:867–877 CrossRef
25.
go back to reference Macdonald J et al (2017) Development of a bifunctional aptamer targeting the transferrin receptor and epithelial cell adhesion molecule (EpCAM) for the treatment of brain cancer metastases. ACS Chem Neurosci 8:777–784 CrossRef Macdonald J et al (2017) Development of a bifunctional aptamer targeting the transferrin receptor and epithelial cell adhesion molecule (EpCAM) for the treatment of brain cancer metastases. ACS Chem Neurosci 8:777–784 CrossRef
26.
go back to reference Jaeger L, Leontis NB (2000) Tecto-RNA: One-Dimensional Self-Assembly through Tertiary Interactions. Angew Chem Int Ed Engl 39:2521–2524 CrossRef Jaeger L, Leontis NB (2000) Tecto-RNA: One-Dimensional Self-Assembly through Tertiary Interactions. Angew Chem Int Ed Engl 39:2521–2524 CrossRef
27.
go back to reference Jaeger L, Westhof E, Leontis NB (2001) TectoRNA: modular assembly units for the construction of RNA nano-objects. Nucleic Acids Res 29:455–463 CrossRef Jaeger L, Westhof E, Leontis NB (2001) TectoRNA: modular assembly units for the construction of RNA nano-objects. Nucleic Acids Res 29:455–463 CrossRef
28.
go back to reference Guo P (2010) The emerging field of RNA nanotechnology. Nat Nanotechnol 5:833–842 CrossRef Guo P (2010) The emerging field of RNA nanotechnology. Nat Nanotechnol 5:833–842 CrossRef
29.
go back to reference Afonin KA et al (2014) Multifunctional RNA nanoparticles. Nano Lett 14:5662–5671 CrossRef Afonin KA et al (2014) Multifunctional RNA nanoparticles. Nano Lett 14:5662–5671 CrossRef
30.
go back to reference Afonin KA et al (2014) Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalities. Nucleic Acids Res 42:2085–2097 CrossRef Afonin KA et al (2014) Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalities. Nucleic Acids Res 42:2085–2097 CrossRef
31.
go back to reference Douglas SM, Bachelet I, Church GM (2012) A logic-gated nanorobot for targeted transport of molecular payloads. Science (New York, N.Y.) 335:831–834 CrossRef Douglas SM, Bachelet I, Church GM (2012) A logic-gated nanorobot for targeted transport of molecular payloads. Science (New York, N.Y.) 335:831–834 CrossRef
32.
go back to reference Halman JR et al (2017) Functionally-interdependent shape-switching nanoparticles with controllable properties. Nucleic Acids Res 45(4):2210–2220 Halman JR et al (2017) Functionally-interdependent shape-switching nanoparticles with controllable properties. Nucleic Acids Res 45(4):2210–2220
33.
go back to reference Afonin KA et al (2013) Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol 8:296–304 CrossRef Afonin KA et al (2013) Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol 8:296–304 CrossRef
34.
go back to reference Afonin KA et al (2014) In silico design and enzymatic synthesis of functional RNA nanoparticles. Acc Chem Res 47:1731–1741 CrossRef Afonin KA et al (2014) In silico design and enzymatic synthesis of functional RNA nanoparticles. Acc Chem Res 47:1731–1741 CrossRef
35.
go back to reference Afonin KA, Lindsay B, Shapiro BA (2013) Engineered RNA nanodesigns for applications in RNA nanotechnology. RNA Nanotechnol 1:1–15 Afonin KA, Lindsay B, Shapiro BA (2013) Engineered RNA nanodesigns for applications in RNA nanotechnology. RNA Nanotechnol 1:1–15
36.
go back to reference Leontis NB, Westhof E (2003) Analysis of RNA motifs. Curr Opin Struct Biol 13:300–308 CrossRef Leontis NB, Westhof E (2003) Analysis of RNA motifs. Curr Opin Struct Biol 13:300–308 CrossRef
37.
go back to reference Leontis NB, Westhof E (2002) The annotation of RNA motifs. Comp Funct Genomics 3:518–524 CrossRef Leontis NB, Westhof E (2002) The annotation of RNA motifs. Comp Funct Genomics 3:518–524 CrossRef
38.
go back to reference Leontis NB, Lescoute A, Westhof E (2006) The building blocks and motifs of RNA architecture. Curr Opin Struct Biol 16:279–287 CrossRef Leontis NB, Lescoute A, Westhof E (2006) The building blocks and motifs of RNA architecture. Curr Opin Struct Biol 16:279–287 CrossRef
39.
go back to reference Afonin KA, Cieply DJ, Leontis NB (2008) Specific RNA self-assembly with minimal paranemic motifs. J Am Chem Soc 130:93–102 CrossRef Afonin KA, Cieply DJ, Leontis NB (2008) Specific RNA self-assembly with minimal paranemic motifs. J Am Chem Soc 130:93–102 CrossRef
40.
go back to reference Afonin KA, Leontis NB (2006) Generating new specific RNA interaction interfaces using C-loops. J Am Chem Soc 128:16131–16137 CrossRef Afonin KA, Leontis NB (2006) Generating new specific RNA interaction interfaces using C-loops. J Am Chem Soc 128:16131–16137 CrossRef
41.
go back to reference Afonin KA et al (2012) Attenuation of loop-receptor interactions with pseudoknot formation. Nucleic Acids Res 40:2168–2180 CrossRef Afonin KA et al (2012) Attenuation of loop-receptor interactions with pseudoknot formation. Nucleic Acids Res 40:2168–2180 CrossRef
42.
go back to reference Bindewald E et al (2011) Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano 5:9542–9551 CrossRef Bindewald E et al (2011) Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano 5:9542–9551 CrossRef
43.
go back to reference Stewart JM et al (2016) Programmable RNA microstructures for coordinated delivery of siRNAs. Nanoscale 8:17542–17550 CrossRef Stewart JM et al (2016) Programmable RNA microstructures for coordinated delivery of siRNAs. Nanoscale 8:17542–17550 CrossRef
44.
go back to reference Afonin KA et al (2010) In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol 5:676–682 CrossRef Afonin KA et al (2010) In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol 5:676–682 CrossRef
45.
go back to reference Afonin KA et al (2011) Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc 6:2022–2034 CrossRef Afonin KA et al (2011) Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc 6:2022–2034 CrossRef
46.
go back to reference Afonin KA et al (2016) The use of minimal RNA toeholds to trigger the activation of multiple functionalities. Nano Lett 16:1746–1753 CrossRef Afonin KA et al (2016) The use of minimal RNA toeholds to trigger the activation of multiple functionalities. Nano Lett 16:1746–1753 CrossRef
47.
go back to reference Grabow WW et al (2011) Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett 11:878–887 CrossRef Grabow WW et al (2011) Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett 11:878–887 CrossRef
48.
go back to reference Afonin KA et al (2015) Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. ACS Nano 9:251–259 CrossRef Afonin KA et al (2015) Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. ACS Nano 9:251–259 CrossRef
49.
go back to reference Bindewald E et al (2016) Multistrand structure prediction of nucleic acid assemblies and design of RNA switches. Nano Lett 16:1726–1735 CrossRef Bindewald E et al (2016) Multistrand structure prediction of nucleic acid assemblies and design of RNA switches. Nano Lett 16:1726–1735 CrossRef
50.
go back to reference Parlea L et al (2016) Cellular delivery of RNA nanoparticles. ACS Comb Sci 18:527–547 CrossRef Parlea L et al (2016) Cellular delivery of RNA nanoparticles. ACS Comb Sci 18:527–547 CrossRef
51.
go back to reference Binzel DW et al (2016) Specific delivery of miRNA for high efficient inhibition of prostate cancer by RNA nanotechnology. Mol Ther 24:1267–1277 CrossRef Binzel DW et al (2016) Specific delivery of miRNA for high efficient inhibition of prostate cancer by RNA nanotechnology. Mol Ther 24:1267–1277 CrossRef
52.
go back to reference Shu D et al (2015) Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology. ACS Nano 9:9731–9740 CrossRef Shu D et al (2015) Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology. ACS Nano 9:9731–9740 CrossRef
53.
go back to reference Rychahou P et al (2015) Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 9:1108–1116 CrossRef Rychahou P et al (2015) Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 9:1108–1116 CrossRef
54.
go back to reference Haque F et al (2012) Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 7:245–257 CrossRef Haque F et al (2012) Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 7:245–257 CrossRef
55.
go back to reference Shu Y et al (2013) Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA (New York, N.Y.) 19:767–777 CrossRef Shu Y et al (2013) Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA (New York, N.Y.) 19:767–777 CrossRef
56.
go back to reference Morrissey DV et al (2005) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology (Baltimore, Md.) 41:1349–1356 CrossRef Morrissey DV et al (2005) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology (Baltimore, Md.) 41:1349–1356 CrossRef
57.
go back to reference Keefe AD, Cload ST (2008) SELEX with modified nucleotides. Curr Opin Chem Biol 12:448–456 CrossRef Keefe AD, Cload ST (2008) SELEX with modified nucleotides. Curr Opin Chem Biol 12:448–456 CrossRef
58.
go back to reference Piao X et al (2017) Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2′-F RNA and LNA in the context of Phi29 pRNA 3WJ. RNA (New York, N.Y.) CrossRef Piao X et al (2017) Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2′-F RNA and LNA in the context of Phi29 pRNA 3WJ. RNA (New York, N.Y.) CrossRef
59.
go back to reference Li H, Labean TH, Leong KW (2011) Nucleic acid-based nanoengineering: novel structures for biomedical applications. Interface Focus 1:702–724 CrossRef Li H, Labean TH, Leong KW (2011) Nucleic acid-based nanoengineering: novel structures for biomedical applications. Interface Focus 1:702–724 CrossRef
60.
go back to reference Keum J-W, Bermudez H (2009) Enhanced resistance of DNA nanostructures to enzymatic digestion. Chem Commun (Cambridge, England) 45:7036–7038 Keum J-W, Bermudez H (2009) Enhanced resistance of DNA nanostructures to enzymatic digestion. Chem Commun (Cambridge, England) 45:7036–7038
61.
go back to reference Toy R et al (2014) Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (London, England) 9:121–134 CrossRef Toy R et al (2014) Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (London, England) 9:121–134 CrossRef
62.
go back to reference Juliano R et al (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36:4158–4171 CrossRef Juliano R et al (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36:4158–4171 CrossRef
63.
go back to reference Roepstorff K et al (2009) Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic (Copenhagen, Denmark) 10:1115–1127 CrossRef Roepstorff K et al (2009) Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic (Copenhagen, Denmark) 10:1115–1127 CrossRef
64.
go back to reference Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461–488 CrossRef Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461–488 CrossRef
65.
go back to reference Robbins M, Judge A, MacLachlan I (2009) siRNA and innate immunity. Oligonucleotides 19:89–102 CrossRef Robbins M, Judge A, MacLachlan I (2009) siRNA and innate immunity. Oligonucleotides 19:89–102 CrossRef
66.
go back to reference Bourquin C et al (2007) Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. Blood 109:2953–2960 Bourquin C et al (2007) Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. Blood 109:2953–2960
67.
go back to reference Radovic-Moreno AF et al (2015) Immunomodulatory spherical nucleic acids. Proc Natl Acad Sci USA 112:3892–3897 CrossRef Radovic-Moreno AF et al (2015) Immunomodulatory spherical nucleic acids. Proc Natl Acad Sci USA 112:3892–3897 CrossRef
68.
go back to reference Khisamutdinov EF et al (2014) Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles. Nucleic Acids Res 42:9996–10004 CrossRef Khisamutdinov EF et al (2014) Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles. Nucleic Acids Res 42:9996–10004 CrossRef
69.
go back to reference Dassie JP et al (2014) Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol Ther: The Journal of the American Society of Gene Therapy 22:1910–1922 CrossRef Dassie JP et al (2014) Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol Ther: The Journal of the American Society of Gene Therapy 22:1910–1922 CrossRef
70.
go back to reference Johnson MB et al (2017) Programmable nucleic acid based polygons with controlled neuroimmunomodulatory properties for predictive QSAR modeling. Small 13:1701255 CrossRef Johnson MB et al (2017) Programmable nucleic acid based polygons with controlled neuroimmunomodulatory properties for predictive QSAR modeling. Small 13:1701255 CrossRef
71.
go back to reference Bui MN et al (2017) Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology. Nanomed Nanotechnol Biol Med 13:1137–1146 CrossRef Bui MN et al (2017) Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology. Nanomed Nanotechnol Biol Med 13:1137–1146 CrossRef
72.
go back to reference Beutler B et al (2006) Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353–389 CrossRef Beutler B et al (2006) Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353–389 CrossRef
73.
go back to reference Moresco EMY, Beutler B (2011) Special delivery: granulin brings CpG DNA to Toll-like receptor 9. Immunity 34:453–455 CrossRef Moresco EMY, Beutler B (2011) Special delivery: granulin brings CpG DNA to Toll-like receptor 9. Immunity 34:453–455 CrossRef
74.
go back to reference Uematsu S, Akira S (2006) Toll-like receptors and innate immunity. J Mol Med (Berlin, Germany) 84:712–725 CrossRef Uematsu S, Akira S (2006) Toll-like receptors and innate immunity. J Mol Med (Berlin, Germany) 84:712–725 CrossRef
75.
go back to reference Motshwene PG et al (2009) An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284:25404–25411 CrossRef Motshwene PG et al (2009) An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284:25404–25411 CrossRef
76.
go back to reference Zhang X et al (2011) Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol (Baltimore, Md.: 1950) 186:4541–4545 CrossRef Zhang X et al (2011) Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol (Baltimore, Md.: 1950) 186:4541–4545 CrossRef
77.
go back to reference Kim T et al (2010) Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA 107:15181–15186 CrossRef Kim T et al (2010) Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA 107:15181–15186 CrossRef
78.
go back to reference Takaoka A et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505 CrossRef Takaoka A et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505 CrossRef
79.
go back to reference Pichlmair A et al (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science (New York, N.Y.) 314:997–1001 CrossRef Pichlmair A et al (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science (New York, N.Y.) 314:997–1001 CrossRef
80.
go back to reference Takeuchi O, Akira S (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20:17–22 CrossRef Takeuchi O, Akira S (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20:17–22 CrossRef
81.
go back to reference Yoneyama M, Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227:54–65 CrossRef Yoneyama M, Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227:54–65 CrossRef
82.
go back to reference Unterholzner L et al (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997–1004 CrossRef Unterholzner L et al (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997–1004 CrossRef
83.
go back to reference Kato H et al (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601–1610 CrossRef Kato H et al (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601–1610 CrossRef
84.
go back to reference Dao BN et al (2015) Triggering RNAi with multifunctional RNA nanoparticles and their delivery. DNA and RNA Nanotechnol 2:1–12 CrossRef Dao BN et al (2015) Triggering RNAi with multifunctional RNA nanoparticles and their delivery. DNA and RNA Nanotechnol 2:1–12 CrossRef
85.
go back to reference Bode C et al (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10:499–511 CrossRef Bode C et al (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10:499–511 CrossRef
86.
go back to reference Shirota H, Klinman DM (2014) Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Rev Vaccines 13:299–312 CrossRef Shirota H, Klinman DM (2014) Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Rev Vaccines 13:299–312 CrossRef
87.
go back to reference Matsuoka N et al (2010) Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides. J Control Release: Official Journal of the Controlled Release Society 148:311–316 CrossRef Matsuoka N et al (2010) Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides. J Control Release: Official Journal of the Controlled Release Society 148:311–316 CrossRef
88.
go back to reference Mohri K et al (2012) Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. ACS Nano 6:5931–5940 CrossRef Mohri K et al (2012) Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. ACS Nano 6:5931–5940 CrossRef
89.
go back to reference Klinman DM, Sato T, Shimosato T (2016) Use of nanoparticles to deliver immunomodulatory oligonucleotides. Wiley Interdiscip Rev. Nanomed Nanobiotechnol 8:631–637 CrossRef Klinman DM, Sato T, Shimosato T (2016) Use of nanoparticles to deliver immunomodulatory oligonucleotides. Wiley Interdiscip Rev. Nanomed Nanobiotechnol 8:631–637 CrossRef
90.
go back to reference Ho PP et al (2003) An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol (Baltimore, Md.: 1950) 171:4920–4926 CrossRef Ho PP et al (2003) An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol (Baltimore, Md.: 1950) 171:4920–4926 CrossRef
91.
go back to reference Hess KL et al (2017) Polyplexes assembled from self-peptides and regulatory nucleic acids blunt Toll-like receptor signaling to combat autoimmunity. Biomaterials 118:51–62 CrossRef Hess KL et al (2017) Polyplexes assembled from self-peptides and regulatory nucleic acids blunt Toll-like receptor signaling to combat autoimmunity. Biomaterials 118:51–62 CrossRef
92.
go back to reference Zhang DY, Seelig G (2011) Dynamic DNA nanotechnology using strand-displacement reactions. Nat Chem 3:103–113 CrossRef Zhang DY, Seelig G (2011) Dynamic DNA nanotechnology using strand-displacement reactions. Nat Chem 3:103–113 CrossRef
93.
go back to reference Li D, Song S, Fan C (2010) Target-responsive structural switching for nucleic acid-based sensors. Acc Chem Res 43(5):631–641 CrossRef Li D, Song S, Fan C (2010) Target-responsive structural switching for nucleic acid-based sensors. Acc Chem Res 43(5):631–641 CrossRef
94.
go back to reference Kagan D et al (2011) Functionalized micromachines for selective and rapid isolation of nucleic acid targets from complex samples. Nano Lett 11:2083–2087 CrossRef Kagan D et al (2011) Functionalized micromachines for selective and rapid isolation of nucleic acid targets from complex samples. Nano Lett 11:2083–2087 CrossRef
95.
go back to reference Liu X, Lu CH, Willner I (2014) Switchable reconfiguration of nucleic acid nanostructures by stimuli-responsive DNA machines. Acc Chem Res 47(6):1673–1680 CrossRef Liu X, Lu CH, Willner I (2014) Switchable reconfiguration of nucleic acid nanostructures by stimuli-responsive DNA machines. Acc Chem Res 47(6):1673–1680 CrossRef
96.
go back to reference Modi S et al (2009) A DNA nanomachine that maps spatial and temporal pH changes inside living cells. Nat Nanotechnol 4:325–330 CrossRef Modi S et al (2009) A DNA nanomachine that maps spatial and temporal pH changes inside living cells. Nat Nanotechnol 4:325–330 CrossRef
97.
go back to reference Mao C et al (1999) A nanomechanical device based on the B-Z transition of DNA. Nature 397(6715):144–146 CrossRef Mao C et al (1999) A nanomechanical device based on the B-Z transition of DNA. Nature 397(6715):144–146 CrossRef
98.
go back to reference Zhou M et al (2010) A light-driven DNA nanomachine for the efficient photoswitching of RNA digestion. Angew Chem Int Ed Engl 49(12):2167–2170 CrossRef Zhou M et al (2010) A light-driven DNA nanomachine for the efficient photoswitching of RNA digestion. Angew Chem Int Ed Engl 49(12):2167–2170 CrossRef
99.
go back to reference Yurke B et al (2000) A DNA-fuelled molecular machine made of DNA. Nature 406(6796):605–608 CrossRef Yurke B et al (2000) A DNA-fuelled molecular machine made of DNA. Nature 406(6796):605–608 CrossRef
100.
go back to reference Bath J, Green SJ, Turberfield AJ (2005) A free-running DNA motor powered by a nicking enzyme. Angew Chem Int Ed Engl 44(28):4358–4361 CrossRef Bath J, Green SJ, Turberfield AJ (2005) A free-running DNA motor powered by a nicking enzyme. Angew Chem Int Ed Engl 44(28):4358–4361 CrossRef
101.
go back to reference Aldaye FA, Palmer AL, Sleiman HF (2008) Assembling materials with DNA as the guide. Science 321(5897):1795–1799 CrossRef Aldaye FA, Palmer AL, Sleiman HF (2008) Assembling materials with DNA as the guide. Science 321(5897):1795–1799 CrossRef
102.
go back to reference Aldaye FA, Sleiman HF (2007) Dynamic DNA templates for discrete gold nanoparticle assemblies: control of geometry, modularity, write/erase and structural switching. J Am Chem Soc 129(14):4130–4131 CrossRef Aldaye FA, Sleiman HF (2007) Dynamic DNA templates for discrete gold nanoparticle assemblies: control of geometry, modularity, write/erase and structural switching. J Am Chem Soc 129(14):4130–4131 CrossRef
103.
go back to reference Park SY et al (2008) DNA-programmable nanoparticle crystallization. Nature 451(7178):553–556 CrossRef Park SY et al (2008) DNA-programmable nanoparticle crystallization. Nature 451(7178):553–556 CrossRef
104.
go back to reference Tyagi S, Kramer FR (1996) Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14(3):303–308 CrossRef Tyagi S, Kramer FR (1996) Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14(3):303–308 CrossRef
106.
go back to reference Zakrevsky P et al (2017) Preparation of a conditional RNA switch. Methods Mol Biol 1632:303–324 CrossRef Zakrevsky P et al (2017) Preparation of a conditional RNA switch. Methods Mol Biol 1632:303–324 CrossRef
107.
go back to reference Xie Z et al (2010) Logic integration of mRNA signals by an RNAi-based molecular computer. Nucleic Acids Res 38(8):2692–2701 CrossRef Xie Z et al (2010) Logic integration of mRNA signals by an RNAi-based molecular computer. Nucleic Acids Res 38(8):2692–2701 CrossRef
108.
go back to reference Xie Z et al (2011) Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333(6047):1307–1311 CrossRef Xie Z et al (2011) Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333(6047):1307–1311 CrossRef
109.
go back to reference Soukup GA, Breaker RR (1999) Nucleic acid molecular switches. Trends Biotechnol 17(12):469–476 CrossRef Soukup GA, Breaker RR (1999) Nucleic acid molecular switches. Trends Biotechnol 17(12):469–476 CrossRef
110.
go back to reference Rinaudo K et al (2007) A universal RNAi-based logic evaluator that operates in mammalian cells. Nat Biotechnol 25(7):795–801 CrossRef Rinaudo K et al (2007) A universal RNAi-based logic evaluator that operates in mammalian cells. Nat Biotechnol 25(7):795–801 CrossRef
111.
go back to reference Penchovsky R, Breaker RR (2005) Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes. Nat Biotechnol 23(11):1424–1433 CrossRef Penchovsky R, Breaker RR (2005) Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes. Nat Biotechnol 23(11):1424–1433 CrossRef
112.
go back to reference Gupta K et al (2015) Bolaamphiphiles as carriers for siRNA delivery: from chemical syntheses to practical applications. J Control Release 213:142–151 CrossRef Gupta K et al (2015) Bolaamphiphiles as carriers for siRNA delivery: from chemical syntheses to practical applications. J Control Release 213:142–151 CrossRef
113.
go back to reference Gupta K et al (2015) Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts. Nanomedicine 10:2805–2818 CrossRef Gupta K et al (2015) Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts. Nanomedicine 10:2805–2818 CrossRef
114.
go back to reference Kim T et al (2013) In silico, in vitro, and in vivo studies indicate the potential use of bolaamphiphiles for therapeutic siRNAs delivery. Mol Ther Nucleic Acids 2:e80 CrossRef Kim T et al (2013) In silico, in vitro, and in vivo studies indicate the potential use of bolaamphiphiles for therapeutic siRNAs delivery. Mol Ther Nucleic Acids 2:e80 CrossRef
115.
go back to reference Byun H-M et al (2004) Erythrocyte ghost-mediated gene delivery for prolonged and blood-targeted expression. Gene Ther 11:492–496 CrossRef Byun H-M et al (2004) Erythrocyte ghost-mediated gene delivery for prolonged and blood-targeted expression. Gene Ther 11:492–496 CrossRef
116.
go back to reference Hung ME, Leonard JN (2016 ) A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J Extracell Vesicles 5:31027 CrossRef Hung ME, Leonard JN (2016 ) A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J Extracell Vesicles 5:31027 CrossRef
117.
go back to reference Smalheiser NR (2007) Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biology Direct 2:35 CrossRef Smalheiser NR (2007) Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biology Direct 2:35 CrossRef
118.
go back to reference Ramachandran S, Palanisamy V (2012) Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 3:286–293 CrossRef Ramachandran S, Palanisamy V (2012) Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 3:286–293 CrossRef
119.
go back to reference Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659 CrossRef Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659 CrossRef
120.
go back to reference Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica. B 6:287–296 CrossRef Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica. B 6:287–296 CrossRef
121.
go back to reference Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 32:1959–1972 CrossRef Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 32:1959–1972 CrossRef
122.
go back to reference Petrocca F, Lieberman J (2011) Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol: Official Journal of the American Society of Clinical Oncolology 29:747–754 CrossRef Petrocca F, Lieberman J (2011) Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol: Official Journal of the American Society of Clinical Oncolology 29:747–754 CrossRef
123.
go back to reference Shen H, Sun T, Ferrari M (2012) Nanovector delivery of siRNA for cancer therapy. Cancer Gene Ther 19:367–373 CrossRef Shen H, Sun T, Ferrari M (2012) Nanovector delivery of siRNA for cancer therapy. Cancer Gene Ther 19:367–373 CrossRef
124.
go back to reference Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–345 CrossRef Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–345 CrossRef
125.
go back to reference El-Andaloussi S et al (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112–2126 CrossRef El-Andaloussi S et al (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112–2126 CrossRef
126.
go back to reference Wahlgren J et al (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40:e130 CrossRef Wahlgren J et al (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40:e130 CrossRef
127.
go back to reference Shtam TA et al (2013) Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell communication and signaling: CCS 11:88 CrossRef Shtam TA et al (2013) Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell communication and signaling: CCS 11:88 CrossRef
128.
go back to reference Banizs AB et al (2014) In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Int J Nanomed 9:4223–4230 Banizs AB et al (2014) In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Int J Nanomed 9:4223–4230
129.
go back to reference Pitt JM et al (2014) Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol (Baltimore, Md.: 1950) 193:1006–1011 CrossRef Pitt JM et al (2014) Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol (Baltimore, Md.: 1950) 193:1006–1011 CrossRef
130.
131.
go back to reference Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464:864–869 CrossRef Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464:864–869 CrossRef
132.
go back to reference Trajkovic K et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (New York, N.Y.) 319:1244–1247 CrossRef Trajkovic K et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (New York, N.Y.) 319:1244–1247 CrossRef
133.
go back to reference Villarroya-Beltri C et al (2014) Sorting it out: regulation of exosome loading. Semin Cancer Biol 28:3–13 CrossRef Villarroya-Beltri C et al (2014) Sorting it out: regulation of exosome loading. Semin Cancer Biol 28:3–13 CrossRef
134.
go back to reference Fader CM et al (2008) Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic (Copenhagen, Denmark) 9:230–250 CrossRef Fader CM et al (2008) Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic (Copenhagen, Denmark) 9:230–250 CrossRef
135.
go back to reference Villarroya-Beltri C et al (2016) ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun 7:13588 CrossRef Villarroya-Beltri C et al (2016) ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun 7:13588 CrossRef
136.
go back to reference De Jong OG et al (2014) Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 5:608 De Jong OG et al (2014) Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 5:608
137.
go back to reference Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289 CrossRef Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289 CrossRef
138.
go back to reference Théry C et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (Baltimore, Md.: 1950) 166:7309–7318 CrossRef Théry C et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (Baltimore, Md.: 1950) 166:7309–7318 CrossRef
139.
go back to reference Ogawa Y et al (2008) Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 31:1059–1062 CrossRef Ogawa Y et al (2008) Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 31:1059–1062 CrossRef
140.
go back to reference Sokolova V et al (2011) Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B, Biointerfaces 87:146–150 CrossRef Sokolova V et al (2011) Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B, Biointerfaces 87:146–150 CrossRef
141.
go back to reference Böing AN (2014) Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles 3 Böing AN (2014) Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles 3
142.
go back to reference Hong CS et al (2014) Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE 9:e103310 CrossRef Hong CS et al (2014) Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE 9:e103310 CrossRef
143.
go back to reference Lee C et al (2012) Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126:2601–2611 CrossRef Lee C et al (2012) Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126:2601–2611 CrossRef
144.
go back to reference Musante L et al (2012) Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. PLoS ONE 7:e37279 CrossRef Musante L et al (2012) Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. PLoS ONE 7:e37279 CrossRef
145.
go back to reference Wubbolts R et al (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278:10963–10972 CrossRef Wubbolts R et al (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278:10963–10972 CrossRef
146.
go back to reference Caby M-P et al (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17:879–887 CrossRef Caby M-P et al (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17:879–887 CrossRef
147.
go back to reference Kim G et al (2012) Noble polymeric surface conjugated with zwitterionic moieties and antibodies for the isolation of exosomes from human serum. Bioconjug Chem 23:2114–2120 CrossRef Kim G et al (2012) Noble polymeric surface conjugated with zwitterionic moieties and antibodies for the isolation of exosomes from human serum. Bioconjug Chem 23:2114–2120 CrossRef
148.
go back to reference Balaj L et al (2015) Heparin affinity purification of extracellular vesicles. Scientific Reports 5:10266 CrossRef Balaj L et al (2015) Heparin affinity purification of extracellular vesicles. Scientific Reports 5:10266 CrossRef
149.
go back to reference Chen C et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10:505–511 CrossRef Chen C et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10:505–511 CrossRef
150.
go back to reference Davies RT et al (2012) Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip 12:5202–5210 CrossRef Davies RT et al (2012) Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip 12:5202–5210 CrossRef
151.
go back to reference Wang Z et al (2013) Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip 13:2879–2882 CrossRef Wang Z et al (2013) Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip 13:2879–2882 CrossRef
152.
go back to reference He M et al (2014) Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip 14:3773–3780 CrossRef He M et al (2014) Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip 14:3773–3780 CrossRef
153.
go back to reference Kanwar SS et al (2014) Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14:1891–1900 CrossRef Kanwar SS et al (2014) Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14:1891–1900 CrossRef
154.
go back to reference Vaidyanathan R et al (2014) Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing. Anal Chem 86:11125–11132 CrossRef Vaidyanathan R et al (2014) Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing. Anal Chem 86:11125–11132 CrossRef
155.
go back to reference Nakai W et al (2016) A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep 6:33935 CrossRef Nakai W et al (2016) A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep 6:33935 CrossRef
156.
go back to reference Wan Y et al (2017) Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng 1 Wan Y et al (2017) Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng 1
157.
go back to reference Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12:153–162 CrossRef Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12:153–162 CrossRef
158.
go back to reference Costa-Silva B et al (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826 CrossRef Costa-Silva B et al (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826 CrossRef
159.
go back to reference Hoshino A et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527:329–335 CrossRef Hoshino A et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527:329–335 CrossRef
160.
go back to reference Jung Y et al (2008) Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem cells (Dayton, Ohio) 26:2042–2051 CrossRef Jung Y et al (2008) Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem cells (Dayton, Ohio) 26:2042–2051 CrossRef
161.
go back to reference Melo SA et al (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177–182 CrossRef Melo SA et al (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177–182 CrossRef
Metadata
Title
Reconfigurable Nucleic Acid Materials for Cancer Therapy
Authors
Morgan Chandler
Weina Ke
Justin R. Halman
Martin Panigaj
Kirill A. Afonin
Copyright Year
2018
DOI
https://doi.org/10.1007/978-3-319-89878-0_11

Premium Partners